TI
TARA icon

Trexquant Investment’s Protara Therapeutics TARA Stock Holding History

Trexquant Investment’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Buy
59,616
+41,683
+232% +$198K ﹤0.01% 1785
2026
Q1 		$93.4K Buy
+17,933
New +$106K ﹤0.01% 1706
2022
Q2 		– Sell
-16,313
Closed -$83K – 1856
2022
Q1 		$83K Buy
16,313
+1,158
+8% +$6.09K ﹤0.01% 1283
2021
Q4 		$102K Buy
15,155
+2,701
+22% +$18.6K 0.01% 1233
2021
Q3 		$86K Buy
+12,454
New +$97.1K 0.01% 1063

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Trexquant Investment's TARA Position: Q2 2026 in Review

Trexquant Investment increased its Protara Therapeutics (TARA) stake by 232% in Q2 2026, buying an estimated $198K and bringing the position to 59,616 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

Trexquant Investment first reported a position in TARA in Q3 2021 and has held it in 5 quarters since. 119 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Trexquant Investment held 59,616 shares of Protara Therapeutics worth $228K as of Q2 2026.
  • Trexquant Investment bought 41,683 Protara Therapeutics shares in Q2 2026, an estimated $198K.
  • Protara Therapeutics made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1785 holding.
  • Trexquant Investment first reported a position in Protara Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.